Fuso Pharmaceutical IndustriesLtd (4538) Stock Overview
Manufactures and sells pharmaceuticals and medical equipment in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
4538 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Fuso Pharmaceutical Industries,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,095.00 |
| 52 Week High | JP¥2,858.00 |
| 52 Week Low | JP¥1,930.00 |
| Beta | 0.23 |
| 1 Month Change | -2.01% |
| 3 Month Change | -4.69% |
| 1 Year Change | -10.89% |
| 3 Year Change | -3.81% |
| 5 Year Change | -16.03% |
| Change since IPO | -78.46% |
Recent News & Updates
Shareholder Returns
| 4538 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -0.05% | -1.5% | -0.4% |
| 1Y | -10.9% | -14.3% | -3.2% |
Return vs Industry: 4538 exceeded the JP Pharmaceuticals industry which returned -14.3% over the past year.
Return vs Market: 4538 underperformed the JP Market which returned -3.2% over the past year.
Price Volatility
| 4538 volatility | |
|---|---|
| 4538 Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.5% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4538 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4538's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | n/a | Mikio Toda | www.fuso-pharm.co.jp |
Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceuticals and medical equipment in Japan. The company offers injectables, infusions, and dialysis agents for artificial kidneys, as well as medical equipment and devices.
Fuso Pharmaceutical Industries,Ltd. Fundamentals Summary
| 4538 fundamental statistics | |
|---|---|
| Market cap | JP¥17.89b |
| Earnings (TTM) | JP¥2.78b |
| Revenue (TTM) | JP¥60.56b |
Is 4538 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4538 income statement (TTM) | |
|---|---|
| Revenue | JP¥60.56b |
| Cost of Revenue | JP¥44.03b |
| Gross Profit | JP¥16.53b |
| Other Expenses | JP¥13.75b |
| Earnings | JP¥2.78b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 08, 2025
| Earnings per share (EPS) | 325.51 |
| Gross Margin | 27.30% |
| Net Profit Margin | 4.59% |
| Debt/Equity Ratio | 66.3% |
How did 4538 perform over the long term?
See historical performance and comparisonDividends
Does 4538 pay a reliable dividends?
See 4538 dividend history and benchmarks| Fuso Pharmaceutical IndustriesLtd dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2025 |
| Dividend Pay Date | Dec 03 2025 |
| Days until Ex dividend | 79 days |
| Days until Dividend pay date | 144 days |
Does 4538 pay a reliable dividends?
See 4538 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/11 10:51 |
| End of Day Share Price | 2025/07/11 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fuso Pharmaceutical Industries,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jayaprabha Dhavale | Virtua Research Inc. |